Trial Details

Not Recruiting
Basic Information
Clinical ID c4987
Identifier ISRCTN58287360
Trial Title Retrospective and prospective evaluation of the pharmacogenetics and metabolites of thiopurine drugs in the treatment of inflammatory bowel disease: a self-controlled trial and a randomised controlled trial
Trial URL Visit Original Page
Study Information
Study Results

NULL

Conditions Inflammatory bowel disease Digestive System Other noninfective gastroenteritis and colitis
Interventions Retrospective self-controlled trial:Retrospectively assess the impact of genetic variation and concentration of metabolites on efficacy and toxicity of AZA/6-MP in patients with IBD.Drug dose was started at 1 mg/kg daily for AZA (Imurel, Glaxo
Participant Information
Sponsor Sun Yat-sen University (China)
City NULL
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement NULL
Study Design
Study Type Interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL